SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 201 filers reported holding SANGAMO THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.77 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $71,037 | -39.8% | 40,362 | +7.5% | 0.00% | 0.0% |
| Q4 2022 | $117,904 | -29.0% | 37,549 | +10.8% | 0.00% | -50.0% |
| Q3 2022 | $166,000 | +19.4% | 33,883 | +1.0% | 0.00% | +100.0% |
| Q2 2022 | $139,000 | -28.4% | 33,556 | +0.3% | 0.00% | -50.0% |
| Q1 2022 | $194,000 | -22.1% | 33,471 | +0.7% | 0.00% | 0.0% |
| Q4 2021 | $249,000 | -17.0% | 33,249 | -0.2% | 0.00% | 0.0% |
| Q3 2021 | $300,000 | -24.2% | 33,313 | +0.6% | 0.00% | -33.3% |
| Q2 2021 | $396,000 | -9.8% | 33,099 | -5.4% | 0.00% | -25.0% |
| Q1 2021 | $439,000 | -19.2% | 34,998 | +0.7% | 0.00% | -20.0% |
| Q4 2020 | $543,000 | +59.2% | 34,770 | -3.8% | 0.01% | +66.7% |
| Q3 2020 | $341,000 | +45.7% | 36,132 | +38.1% | 0.00% | 0.0% |
| Q2 2020 | $234,000 | +35.3% | 26,168 | -3.9% | 0.00% | 0.0% |
| Q1 2020 | $173,000 | – | 27,218 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WASATCH ADVISORS LP | 17,986,781 | $10,788,471 | 0.07% |
| PUBLIC EMPLOYEES RETIREMENT ASSOCIATION OF COLORADO | 254,257 | $12,790 | 0.03% |
| Long Focus Capital Management, LLC | 1,372,000 | $822,926 | 0.03% |
| GSA CAPITAL PARTNERS LLP | 559,731 | $336 | 0.03% |
| Rokos Capital Management LLP | 6,474,348 | $3,940,936 | 0.03% |
| Golden State Equity Partners | 166,265 | $99,726 | 0.03% |
| State of Wyoming | 92,360 | $55,398 | 0.01% |
| ExodusPoint Capital Management, LP | 1,890,425 | $1,134 | 0.01% |
| ACADIAN ASSET MANAGEMENT LLC | 2,927,769 | $1,753 | 0.01% |
| Fort Sheridan Advisors LLC | 53,831 | $32,288 | 0.01% |